Abstract
Sera from 2,008 pregnant women were examined for the presence of complement-fixing platelet antibodies (CFPAb) and lymphocytotoxic antibodies (LCTAb). Women with antibodies in their serum were compared with women without antibodies. No clinical significance of CFPAb or LCTAb was found as regards pre-eclampsia, arterial hypertension, albuminuria, oedema, glucosuria, premature delivery, spontaneous onset of labor and abortion.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.